Calcium channel blocker, Diabetes mellitus type 2, Nitric oxide synthase, Pharmacogenetics
dx.doi.org/10.1007/s00125-008-1143-4, hdl.handle.net/1765/29099
Diabetologia: clinical and experimental diabetes and metabolism
Erasmus MC: University Medical Center Rotterdam

Becker, M.L, Visser, L.E, Newton-Cheh, C, Witteman, J.C.M, Hofman, A, Uitterlinden, A.G, & Stricker, B.H.Ch. (2008). Genetic variation in the NOS1AP gene is associated with the incidence of diabetes mellitus in users of calcium channel blockers. Diabetologia: clinical and experimental diabetes and metabolism, 51(11), 2138–2140. doi:10.1007/s00125-008-1143-4